Drug Trial Radar · NCT03022916
Real-World Evaluation of the Effect of Jublia on Nail Polish
Last checked: Nov 20, 2026Latest source record: Jan 6, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5
Actual
Start
Sep 2015
Primary completion
Sep 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- University of Alabama at BirminghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 18, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A recent publication using cadaver nails suggests that Jublia application has a negative effect on nail polish texture.
Conditions
- Evaluation of Jublia on Nail Polish With Healthy Toenails
Interventions
Nail Polish + Efinaconazole SolutionDrug
Application of Jublia to the nail of one big toe on top of the nail polish
Nail polishOther
Application of nail polish only to both big toe nails
Base Coat + Nail Polish + Top Coat + Efinaconazole SolutionDrug
Application of Jublia to the nail of one big toe on top of the nail polish with layers of top coat and base coat
Nail Polish + Top Coat + Efinaconazole SolutionDrug
Application of Jublia to the nail of one big toe on top of the nail polish with layer of top coat
Primary outcomes
What the sponsor says the trial is designed to measure.
- Observe Stability of Nail Polish as Evidenced by Serial Photography With Efinaconazole Application in Terms of DaysTime frame: Baseline to 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Kirklin Clinic
Birmingham, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.